** Shares of China's biopharmaceuticals products developer Zai Lab Ltd 9688.HK jump 17.1% to HK$32.5, their highest since March 2023, and on course for the second session of gains
** Stock set for the biggest one-day jump since May 9, 2024; second-biggest gainer on healthcare index .HSCIH, which is trading up 1.4%
** Zai Lab, with current market capitalisation of HK$34.26 bln ($4.41 bln), said its 2024 net product revenue increased 49% y/y to $397.6 mln, while R&D expenses decreased 12% y/y to $234.5 mln and net loss reduced 23% y/y to $257.1 mln
** Hang Seng Commerce & Industry Index .HSNC slips 0.7%, Hang Seng Index .HSI eases 0.6%
** Stock up 49% YTD
($1 = 7.7766 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。